Mariner
RMD icon

Mariner’s ResMed RMD Stock Holding History

Mariner’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.81M Sell
39,250
-24,674
-39% -$6.15M 0.01% 802
2025
Q4 		$15.4M Sell
63,924
-9,465
-13% -$2.42M 0.02% 530
2025
Q3 		$20.1M Sell
73,389
-1,525
-2% -$417K 0.03% 417
2025
Q2 		$19.3M Buy
74,914
+1,530
+2% +$365K 0.03% 423
2025
Q1 		$16.4M Sell
73,384
-166
-0.2% -$38.8K 0.03% 424
2024
Q4 		$16.8M Buy
73,550
+2,890
+4% +$696K 0.03% 404
2024
Q3 		$17.2M Buy
70,660
+10,048
+17% +$2.25M 0.03% 394
2024
Q2 		$11.6M Buy
60,612
+3,708
+7% +$752K 0.02% 472
2024
Q1 		$11.3M Buy
56,904
+43,697
+331% +$8.01M 0.02% 479
2023
Q4 		$2.27M Buy
13,207
+5,971
+83% +$917K 0.01% 1004
2023
Q3 		$1.07M Sell
7,236
-2,702
-27% -$489K ﹤0.01% 1284
2023
Q2 		$2.17M Buy
9,938
+108
+1% +$24.1K 0.01% 939
2023
Q1 		$2.15M Sell
9,830
-361
-4% -$78.3K 0.01% 927
2022
Q4 		$2.12M Sell
10,191
-1,909
-16% -$419K 0.01% 906
2022
Q3 		$2.64M Buy
+12,100
New +$2.75M 0.01% 675

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mariner's RMD Position: Q1 2026 in Review

Mariner reduced its ResMed (RMD) stake by 39% in Q1 2026, selling an estimated $6.15M and leaving 39,250 shares worth $8.81M. The position accounts for 0.01% of the portfolio, ranked #802.

Mariner first reported a position in RMD in Q3 2022 and has held it in 15 quarters since. The position peaked at $20.1M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Mariner held 39,250 shares of ResMed worth $8.81M as of Q1 2026.
  • Mariner sold 24,674 ResMed shares in Q1 2026, an estimated $6.15M.
  • ResMed made up 0.01% of Mariner's portfolio in Q1 2026, its #802 holding.
  • Mariner first reported a position in ResMed in Q3 2022 and has held it in 15 quarters since.
  • Mariner's ResMed position peaked at $20.1M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.